Vir Biotechnology, Inc. (Nasdaq: VIR), today provided a corporate update and reported financial results for the fourth quarter and full year ended December 31, 2024.
Interesting Engineering on MSN9h
Low-cost drone daredevils to slash search risk in dark and deadly rescue missionsA new drone system with 3D mapping technology has been developed to aid in indoor search and rescue operations during ...
Proceeds to support advancement of BX004 program through Phase 2b study topline results in cystic fibrosis (CF) patients, anticipated in Q1 ...
Masked Analysis Shows Participants Receiving Oral Zervimesine for at Least 6 Months Experienced Slower Lesion Growth than Participants Receiving ...
Savarkar’s search for the meaning of the term ‘Hindu’ led him to craft a broader narrative of ‘Hindudom’. But how did he ...
The Brit Awards have announced that English pop star Charli XCX will be taking home the competition’s songwriting prize, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback